Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Transplantation. 2019 Dec;103(12):2531–2538. doi: 10.1097/TP.0000000000002733

Table 1:

Baseline clinical and demographic characteristics

n=20,121
Variable Hispanic
N=3279
White
N=9150
Black
N=4432
Asian
N=529
Other
N=2731
P Value
Age-years 55±12 58±12 57±11 58±12 57±12 <.0001a
Male- n (%) 2002 (61) 5292 (58) 2357 (53) 318 (60) 1153 (57) <.0001c
Diagnoses present- n (%)
Alcohol 1430 (44) 3077 (34) 1263 (29) 80 (15) 792 (29) <.0001c
Hepatitis C 1160 (35) 3325 (36) 2509 (57) 193 (36) 973 (36) <.0001c
NASH 810 (25) 2066 (22) 792 (18) 84 (16) 427 (16) <.0001c
Hepatitis B 189 (6) 477 (5) 545 (12) 222 (42) 223 (8) <.0001c
Hepatocellular Carcinoma 398 (12) 1386 (15) 538 (12) 131 (25) 372 (14) <.0001
Diagnoses per patient-mean (IQR) 1.32 (1-2) 1.26 (1-2) 1.35 (1-2) 1.43 (1-2) 1.13 (1-2) <.0001
Median Elixhauser Score-(IQR) 3 (2-6) 3 (1-6) 5 (2-8) 2 (1-5) 1 (0-4) <.0001b
Insurance- n (%)
Medicare/Medicaid 1383 (42) 4591 (50) 2581 (58) 193 (36) 1298 (48) <.0001c
Private Insurance 885 (27) 3733 (41) 992 (22) 165 (31) 1095 (40)
Other 1011 (31) 826 (9) 859 (19) 171 (32) 338 (12)
Deaths (%) 760 (23) 2624 (29) 1376 (31) 112 (21) 850 (31) <.0001c
Transplant (%) 107 (3) 609 (7) 81 (2) 27 (5) 95 (4) <.0001c

Categories are not mutually exclusive

a

ANOVA

b

Kruksal Wallis test

c

Chi-square